TAVIN TENOFOVIR DISOPROXIL FUMARATE TABLETS

Get a Price/Quote

TAVIN TENOFOVIR DISOPROXIL FUMARATE TABLETS Specification

Dosage Form
Film-coated Tablet

Indication
Indicated for the treatment of HIV-1 infection and chronic hepatitis B infection

Pacakaging (Quantity Per Box)
30 Tablets per bottle/box

Salt Composition
Tenofovir Disoproxil Fumarate

Origin of Medicine
India

Drug Type
Allopathic

Ingredients
Tenofovir Disoproxil Fumarate

Physical Form
Tablets

Function
Antiretroviral agent, Nucleotide Reverse Transcriptase Inhibitor

Recommended For
HIV-1 Infection, Chronic Hepatitis B Infection

Dosage
As directed by physician, typically 300 mg once daily

Dosage Guidelines
Take with or without food; swallow tablet whole with water

Suitable For
Adults and adolescents (aged 12 years and older, weighing at least 35 kg)

Quantity
30 Tablets

Storage Instructions
Store below 30C, in a dry place, protect from light

TAVIN TENOFOVIR DISOPROXIL FUMARATE TABLETS Trade Information

Packaging Details
PACK OF 30 TABLETS

Main Domestic Market
All India

About TAVIN TENOFOVIR DISOPROXIL FUMARATE TABLETS

Tavin Tablets

Specifications:-

Brand Name: Tavin
Content: Tenofovir Disoproxil Fumarate
Strengths:300 Mg
Form: Tablet
Packing: Pack of 30 Tablet
Manufactured By: Emcure

Note :- Tavin Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.............

Efficient HIV and Hepatitis B Management

TAVIN Tenofovir Disoproxil Fumarate tablets are clinically proven to suppress HIV-1 and chronic hepatitis B infections. As a nucleotide reverse transcriptase inhibitor, TAVIN effectively hinders viral replication, helping patients maintain healthier immune functions and slowing disease progression. Its convenient once-daily dosage supports adherence to treatment protocols.

Convenient Oral Dosage Form

Formulated as film-coated, oval tablets, TAVIN is easy to swallow and suitable for both adults and adolescents over 12 years and weighing at least 35 kg. The tablets come in a secure HDPE bottle, ensuring product stability and protection from moisture and light, with 30 tablets per bottle for patient convenience.

Safety and Storage

TAVIN tablets feature a shelf life of 24 months and must be stored below 30C, in a dry place and protected from light to preserve efficacy. Common side effects include nausea, diarrhea, headache, dizziness, and fatigue. Always use under medical supervision and keep away from children.

FAQs of TAVIN TENOFOVIR DISOPROXIL FUMARATE TABLETS:

Q: How should TAVIN Tenofovir Disoproxil Fumarate 300 mg tablets be taken?

A: Take one tablet by mouth, once daily, as prescribed by your physician. The tablet should be swallowed whole with water, and can be taken with or without food. Do not crush or split the tablet.

Q: What are the primary indications for using TAVIN tablets?

A: TAVIN is indicated for the treatment of HIV-1 infection and chronic hepatitis B infection in adults and adolescents aged 12 years and older who weigh at least 35 kg.

Q: When should TAVIN tablets be used during the course of infection?

A: TAVIN is prescribed as part of a long-term treatment regimen for HIV-1 and chronic hepatitis B. Use the medication consistently as directed by your doctor to suppress viral replication and slow disease progression.

Q: Where should TAVIN tablets be stored to maintain their effectiveness?

A: Store TAVIN tablets below 30C, in a dry place, and protect them from direct light. Always keep the medication in its original HDPE bottle and out of reach of children.

Q: What benefits does TAVIN offer as an antiretroviral agent?

A: TAVIN helps reduce the viral load in patients with HIV-1 or chronic hepatitis B, supporting improved immune function, slowing disease progression, and lowering the risk of transmission when used according to your physicians guidelines.

Q: What common side effects should I be aware of when taking TAVIN?

A: Typical side effects can include nausea, diarrhea, headache, dizziness, and fatigue. If you experience any severe or persistent reactions, consult your healthcare provider promptly.

Q: Is TAVIN suitable for all patients with HIV or chronic hepatitis B?

A: TAVIN is approved for adults and adolescents aged 12 and older, and weighing at least 35 kg. It should be used strictly under medical supervision, and is not recommended for children under 12 years or for those below the required weight threshold.

Tell us about your requirement